Related Experiment Video
Updated: Mar 25, 2026
08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
5.1K
Alterations in Mitochondrial Quality Control in Alzheimer's Disease
1Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey Piscataway, NJ, USA.
Frontiers in Cellular Neuroscience
|February 24, 2016
Summary
Mitochondrial dysfunction is key in Alzheimer's disease (AD) pathogenesis. This review examines how altered mitochondrial dynamics and mitophagy contribute to neuronal dysfunction in AD.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Mitochondrial dysfunction is an early hallmark of Alzheimer's disease (AD).
- Neurons heavily rely on mitochondrial function due to their high metabolic activity.
- Mitochondrial dynamics (fusion/fission) and mitophagy are crucial for maintaining mitochondrial health.
Purpose of the Study:
- To review recent findings on mitochondrial dynamics and mitophagy alterations in Alzheimer's disease.
- To discuss the impact of these changes on mitochondrial quality control and neuronal dysfunction in AD.
Main Methods:
- Literature review of studies on mitochondrial dynamics and mitophagy in AD.
- Analysis of research on AD brain and mouse models.
Main Results:
- Significant alterations in mitochondrial dynamics (fusion/fission) are observed in AD.
- Dysfunctional mitophagy pathways are implicated in AD pathogenesis.
- These abnormalities impair mitochondrial quality control in vulnerable neurons.
Conclusions:
- Altered mitochondrial dynamics and mitophagy are critical contributors to mitochondrial dysfunction in Alzheimer's disease.
- Targeting these pathways may offer therapeutic strategies for AD.
Keywords:
Alzheimer’s diseaseaxonal transportmitochondrial dynamicsmitochondrial quality controlmitochondrial transportmitophagosomemitophagyMore Related Videos
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
1.3K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.4K
Related Concept Videos
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:37Mitochondria
21.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.3K
01:46Electron Transport Chain: Complex I and II
19.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:45Mitochondrial Membranes
17.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.7K
01:19Translocation of Proteins into the Mitochondria
13.7K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.7K